CYFRA 21-1 serum levels in women with adnexal masses and inflammatory diseases.

The aim of the present study was to evaluate the clinical usefulness of the cytokeratin marker CYFRA 21-1 as a screening marker for ovarian cancer, as a predictive marker in patients with adnexal masses and as a prognostic marker in women suffering from ovarian cancer. In order to determine the spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Tempfer, C., Hefler, L., Heinzl, H., Loesch, A., Gitsch, G., Rumpold, H., Kainz, C.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063147/
https://www.ncbi.nlm.nih.gov/pubmed/9792159

Ejemplares similares

Ejemplares similares